SCHEMBL5226719

SCHEMBL5226719

CC(C)(O)c1cccc(C(C)(C)O)c1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.44
PGR P06401 1/20 0.43
GABRA1 P14867 1/20 0.38
GABRB2 P47870 1/20 0.38
ALDH1A1 P00352 3/20 0.37
TSHR P16473 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 1/20 0.35
GLA P06280 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3072904 0.86 CD44 (0.48) CA2PGRGABRA1GABRB2ALDH1A1
SCHEMBL29636630 0.84 PGR (0.45) CA2PGRGABRA1GABRB2ALDH1A1
SCHEMBL25510426 0.84 PGR (0.38) CA2PGRGABRA1GABRB2ALDH1A1
SCHEMBL23162712 0.84 PGR (0.45) CA2PGRGABRA1GABRB2ALDH1A1
SCHEMBL27690852 0.81 PNMT (0.36) CA2PGRGABRA1GABRB2
SCHEMBL6183839 0.81 CYP3A4 (0.50) CA2PGRGABRA1GABRB2ALDH1A1
SCHEMBL18534722 0.80 ALOX12 (0.35) CA2PGRALOX12
SCHEMBL18534926 0.80 PGR (0.35) CA2PGRALDH1A1KDM4EMEN1
SCHEMBL138254 0.78 CA2 (0.55) CA2GABRA1GABRB2ALDH1A1TSHR
SCHEMBL29506834 0.77 ALDH1A1 (0.50) CA2PGRGABRA1GABRB2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152231-A9 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR UMICORE AG & CO. KG (DE) 2017-06-01 US disclosed
US-20070287086-A1 Colored photosensitive resin composition, color filter, image sensor, and camera system SONY CORPORATION (JP) 2007-12-13 US disclosed
US-20070287087-A1 Colored photosensitive resin composition, color filter, image sensor, and camera system SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-12-13 US disclosed
EP-1860502-A1 Colored photosensitive resin composition, color filter, image sensor, and camera system Sumitomo Chemical Company, Limited (JP) 2007-11-28 EP disclosed
EP-1860503-A2 Colored photosensitive resin composition, color filter, image sensor, and camera system Sumitomo Chemical Company, Limited (JP) 2007-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152231-A9 SYNTHESES OF N-HETEROCYCLIC CARBENES AND INTERMEDIATES THEREFOR GRHPR, DDC, WEE2 CA2 902/4885PGR 2213/4885GABRA1 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.